Cipla: Strong Traction in Domestic, US; Outlook Positive
65 therapeutic categories, with over 50 dosage forms. Cipla supplies branded and generic medicines to over 170 countries globally. Cipla derives...
264 Views
HSIE Results Daily: Cipla, Torrent Pharma, Shriram Transport Finance Company, Supreme Industries,...
Federal Bank: Federal Bank (FB)'s Q3FY22 earnings were broadly in line with our estimates as declining credit costs (64bps) were partially...
418 Views
Cipla (Results Review 2QFY22): In-line quarter; upbeat on outlook. Maintain BUY
The US business witnessed improved traction and grew ~1% QoQ, led by market share gains in Albuterol and Arformoterol. Its respiratory pipeline in...
174 Views
Cipla: Strong Q1 Led by Core Therapies, Covid Portfolio
Indian branded formulations business accounts for ~40% of revenues and enjoys leadership in therapies like respiratory, anti-infective, cardiac,...
211 Views
HSIE Results Daily: Godrej Consumers, Cipla, GAIL, Gujarat Gas, Hindustan Petroleum Corporation,...
Aditya Birla Capital: As outlined in our Initiation note, Aditya Birla Capital (ABCL) continues on its journey towards a credible makeover, driving...
397 Views